These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time. Hafström L; Rudenstam CM; Domellöf L Br J Surg; 1985 Feb; 72(2):138-41. PubMed ID: 3882183 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK). Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant cytotoxic liver perfusion for colorectal cancer. Taylor I; Rowling J; West C Br J Surg; 1979 Dec; 66(12):833-7. PubMed ID: 509055 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial. Taylor I; Brooman P; Rowling JT Br Med J; 1977 Nov; 2(6098):1320-2. PubMed ID: 338105 [TBL] [Abstract][Full Text] [Related]
7. A new catheter to simplify portal vein cannulation for adjuvant cytotoxic liver perfusion following resection of rectal cancer. Ashley S; Sutton G; Royle G; Taylor I Br J Cancer; 1990 May; 61(5):763-4. PubMed ID: 2337513 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Wereldsma JC; Bruggink ED; Meijer WS; Roukema JA; van Putten WL Cancer; 1990 Feb; 65(3):425-32. PubMed ID: 2404556 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Wolmark N; Rockette H; Wickerham DL; Fisher B; Redmond C; Fisher ER; Potvin M; Davies RJ; Jones J; Robidoux A J Clin Oncol; 1990 Sep; 8(9):1466-75. PubMed ID: 2202789 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy of colorectal cancer. Kemeny N; Saltz L; Cohen A Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research. Rougier P; Sahmoud T; Nitti D; Curran D; Doci R; De Waele B; Nakajima T; Rauschecker H; Labianca R; Pector JC; Marsoni S; Apolone G; Lasser P; Couvreur ML; Wils J Lancet; 1998 Jun; 351(9117):1677-81. PubMed ID: 9734883 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant portal infusion chemotherapy in colorectal cancer. Metzger U Recent Results Cancer Res; 1988; 110():95-100. PubMed ID: 3043601 [No Abstract] [Full Text] [Related]
13. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Beart RW; Moertel CG; Wieand HS; Leigh JE; Windschitl HE; van Heerden JA; Fitzgibbons RJ; Wolff BG Arch Surg; 1990 Jul; 125(7):897-901. PubMed ID: 2369315 [TBL] [Abstract][Full Text] [Related]
15. Should Dukes' B patients receive adjuvant therapy? A statistical perspective. Buyse M; Piedbois P Semin Oncol; 2001 Feb; 28(1 Suppl 1):20-4. PubMed ID: 11273585 [TBL] [Abstract][Full Text] [Related]
16. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality. Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965 [No Abstract] [Full Text] [Related]
17. Cannulation of the portal vein for cytotoxic liver perfusion in colorectal carcinomas: an alternative approach. Hunt TM; Windle R Ann R Coll Surg Engl; 1987 Jan; 69(1):36-8. PubMed ID: 3566116 [TBL] [Abstract][Full Text] [Related]
18. [Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancer--results of a randomized trial]. Wan DS Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):388-91. PubMed ID: 2854781 [TBL] [Abstract][Full Text] [Related]
19. Effect of razoxane on metastases from colorectal cancer. Hellmann K; Gilbert J; Evans M; Cassell P; Taylor R Clin Exp Metastasis; 1987; 5(1):3-8. PubMed ID: 3829494 [TBL] [Abstract][Full Text] [Related]
20. [Isolated liver perfusion with 5-fluorouracil (5-FU) in the human]. Aigner K; Walther H; Tonn JC; Krahl M; Wenzl A; Merker G; Schwemmle K Chirurg; 1982 Sep; 53(9):571-3. PubMed ID: 7172834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]